ask="7.13"
ask_size="300"
average_daily_volume="183547"
bid="2.70"
bid_size="2100"
book_value="3.40"
change="-0.01"
change_from_200_day_moving_average="-0.46"
change_from_50_day_moving_average="-0.12"
change_from_52_week_high="-4.44"
change_From_52_week_low="1.10"
change_in_percent="-0.34%"
close="2.95"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-7.49"
ebitda="-7.62M"
eps_estimate_current_year="-1.18"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.27"
ex_dividend_date="N/A"
float_shares="2302000"
high="3.00"
high_52_weeks="7.39"
last_trade_date="2/17/2017"
last_trade_price="2.95"
last_trade_size="200"
last_trade_time="3:59pm"
low="2.92"
low_52_weeks="1.85"
market_capitalization="29.16M"
moving_average_200_day="3.41"
moving_average_50_day="3.07"
name="Cesca Therapeutics Inc."
notes="N/A"
one_year_target_price="2.00"
open="2.97"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-13.43%"
percent_change_from_50_day_moving_average="-3.86%"
percent_change_from_52_week_high="-60.08%"
percent_change_from_52_week_low="+59.45%"
previous_close="2.96"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.87"
price_per_sales="2.15"
revenue="13.58M"
shares_outstanding="9886000"
short_ratio="3.86"
stock_exchange="NCM"
symbol="KOOL"
volume="5657"
weeks_range_52="1.85 - 7.39"
